Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)

Publication | Open Access

DOI Full Paper Access

Citations

References

2020

Year

Koos de Wit, Jelte J. Schaapman, Frederik Nevens, Jef Verbeek, Samuel Coenen, Frans J.C. Cuperus, M. Kramer, Eric T.T.L. Tjwa, Nahid Mostafavi, M.G.W. Dijkgraaf,

BMJ Open Gastroenterology

Abstract

References